FibroBiologics, Inc. is a biotechnology company focused on developing innovative cell therapies and regenerative medicine solutions, primarily utilizing fibroblast cells
The company aims to address various medical conditions by harnessing the unique properties of these cells, which play a crucial role in wound healing and tissue repair. Through advanced research and clinical development, FibroBiologics seeks to create effective treatments for conditions such as chronic wounds, orthopedic injuries, and other degenerative diseases, ultimately improving the quality of life for patients through its cutting-edge therapeutic approaches.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.14% to 38,204.88 while the NASDAQ rose 0.77% to 15,281.03. The S&P 500 also rose, gaining, 0.49% to 4,869.54.
Shares of C.H. Robinson Worldwide, Inc. (NASDAQCHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
